Millennial Uses Obscure 18-Digit Code to Beat Wall Street
Andrew Keene was "down and out"... until he found an obscure 18-digit "code" that let him see when hedge funds were making incredibly lucrative trades. He realized he could follow along - and take a slice of the profit. He's now a multi-millionaire.
And you can see how his strategy works here.
pixel

ICPT Insider Trading (Intercept Pharmaceuticals)

Insider Ownership Percentage: 23.70%
Insider Buying (Last 12 Months): $5,016,030.00
Insider Selling (Last 12 Months): $121,823,456.08

Intercept Pharmaceuticals Insider Trading History Chart

Intercept Pharmaceuticals Share Price & Price History

$22.17
▼ -1.17 (-5.01%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
Emergency Briefing: “The Great Reset”
By May 28th, Americans could be faced with a difficult choice: Accept a "Great Reset" and risk losing the American way of life... or stand up and fight back to save what's left of the American dream. Jeff Brown, a member of a D.C.-based advocacy group, explains what every American must do before May 28th to preserve his assets and thrive.
Click here to see this emergency briefing before i

Intercept Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/12/2021Srinivas AkkarajuDirectorBuy147,000$21.29$3,129,630.0023,121  
3/10/2021Srinivas AkkarajuDirectorBuy90,000$20.96$1,886,400.0023,121  
1/5/2021Sandip KapadiaCFOSell2,193$24.47$53,662.71
12/15/2020Sandip KapadiaCFOSell1,763$32.78$57,791.1427,158  
8/18/2020Jason CampagnaInsiderSell1,192$47.44$56,548.488,778  
8/17/2020S.P.A. GenextraMajor ShareholderSell1,362,400$47.07$64,128,168.005,417,000  
8/14/2020Paolo FundaroDirectorSell54,600$50.55$2,760,030.0021,028  
8/13/2020S.P.A. GenextraMajor ShareholderSell83,000$52.60$4,365,800.005,417,000  
5/13/2020Paolo FundaroDirectorSell595,578$84.60$50,385,898.8019,433  
4/27/2020Christian WeyerEVPSell181$85.95$15,556.9517,140  
4/9/2020David A FordInsiderSell58$70.00$4,060.0013,882  
2/27/2020Christian WeyerEVPSell113$87.62$9,901.0617,480  
1/27/2020Christian WeyerEVPSell723$94.04$67,990.9218,560  
1/7/2020Jason CampagnaInsiderSell732$113.02$82,730.646,303  
1/3/2020David A FordInsiderSell259$117.16$30,344.4410,945  
12/27/2019Christian WeyerEVPSell1,581$123.24$194,842.4415,705  
12/26/2019Gail CawkwellSVPSell54$125.00$6,750.0018,776  
12/26/2019Mark PruzanskiCEOSell417$125.00$52,125.00469,543  
12/19/2019Jason CampagnaInsiderSell154$119.45$18,395.307,444  
11/26/2019Christian WeyerEVPSell4,373$100.00$437,300.0017,509  
11/26/2019Mark PruzanskiCEOSell35,437$100.00$3,543,700.00469,165  
11/19/2019Christian WeyerEVPSell1,550$85.00$131,750.0015,759  
11/19/2019Ryan T SullivanGeneral CounselSell12,154$85.00$1,033,090.0034,043  
11/13/2019Christian WeyerEVPSell946$85.00$80,410.0017,309  
11/13/2019Ryan T SullivanGeneral CounselSell500$85.00$42,500.0026,929  
10/29/2019Lisa BrightInsiderSell595$75.00$44,625.0018,732  
10/23/2019David A FordInsiderSell58$70.00$4,060.0011,396  
9/16/2019David A FordInsiderSell800$70.00$56,000.0011,546  
8/28/2019Srinivas AkkarajuDirectorBuy5,207$60.32$314,086.2421,526  
8/22/2019Srinivas AkkarajuDirectorBuy67,784$66.37$4,498,824.08  
7/3/2019Lisa BrightInsiderSell595$78.66$46,802.7020,452  
5/14/2019Luca BenattiDirectorBuy1,200$83.50$100,200.007,556  
5/1/2019David ShapiroInsiderSell2,000$86.28$172,560.0041,499  
4/15/2019David ShapiroInsiderSell2,000$95.00$190,000.0041,499  
4/3/2019David ShapiroInsiderSell562$115.01$64,635.6240,061  
3/29/2019Paolo FundaroDirectorSell2,171$107.45$233,273.9511,114  
3/1/2019Christian WeyerEVPSell333$103.16$34,352.2819,440  
3/1/2019David ShapiroInsiderSell2,000$103.16$206,320.0042,543  
2/19/2019Srinivas AkkarajuDirectorSell23,438$128.78$3,018,345.64  
2/15/2019David ShapiroInsiderSell2,000$111.51$223,020.0042,543  
1/7/2019Lisa BrightInsiderSell1,313$104.93$137,773.0918,807  
1/4/2019David ShapiroInsiderSell474$97.48$46,205.5237,243  
1/2/2019David ShapiroInsiderSell2,000$98.28$196,560.0038,416  
12/17/2018David ShapiroInsiderSell2,000$106.62$213,240.0041,152  
12/4/2018Lisa BrightInsiderSell5,000$111.42$557,100.0022,488  
11/29/2018Christian WeyerEVPSell1,343$113.78$152,806.5417,162  
11/29/2018S.P.A. GenextraMajor ShareholderSell750,000$105.07$78,802,500.006,095,578  
11/16/2018Mark PruzanskiCEOSell50,000$101.07$5,053,500.00589,199  
11/1/2018David ShapiroInsiderSell2,000$96.32$192,640.0041,152  
10/15/2018David ShapiroInsiderSell3,425$102.95$352,603.7542,577  
10/5/2018David ShapiroInsiderSell759$110.65$83,983.3539,152  
9/5/2018David ShapiroInsiderSell4,917$111.43$547,901.3142,196  
See Full Table

SEC Filings (Institutional Ownership Changes) for Intercept Pharmaceuticals (NASDAQ:ICPT)

85.77% of Intercept Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Intercept Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
4/5/2021Pacer Advisors Inc.3,711$86K0.0%-13.8%0.011%
3/24/2021Alpha DNA Investment Management LLC22,258$0.55M0.6%N/A0.067%
3/2/2021Norges Bank193,621$4.78M0.0%N/A0.587%
2/24/2021Virtu Financial LLC9,911$0.25M0.0%N/A0.030%
2/23/2021Principal Financial Group Inc.89,115$2.20M0.0%+46.7%0.270%
2/17/2021Voloridge Investment Management LLC371,324$9.17M0.1%+17.9%1.125%
2/17/2021Canada Pension Plan Investment Board28,070$0.69M0.0%+56.2%0.085%
2/16/2021Walleye Capital LLC37,453$0.93M0.1%+177.2%0.114%
2/16/2021Nuveen Asset Management LLC97,392$2.41M0.0%-56.1%0.295%
2/16/2021Davidson Kempner Capital Management LP162,800$4.02M0.1%N/A0.493%
2/16/2021Alpha DNA Investment Management LLC24,618$0.61M0.6%N/A0.075%
2/16/2021Virginia Retirement Systems ET AL12,600$0.31M0.0%N/A0.038%
2/16/2021Engineers Gate Manager LP55,590$1.37M0.1%+40.5%0.168%
2/16/2021Prelude Capital Management LLC13,830$0.34M0.0%+13,730.0%0.042%
2/16/2021ExodusPoint Capital Management LP18,929$0.47M0.0%N/A0.057%
2/16/2021Charles Schwab Investment Management Inc.202,701$5.01M0.0%+0.8%0.614%
2/13/2021American International Group Inc.15,071$0.37M0.0%-2.8%0.046%
2/12/2021The Manufacturers Life Insurance Company 15,801$0.39M0.0%+3.1%0.048%
2/12/2021Credit Suisse AG131,613$3.25M0.0%-66.1%0.399%
2/12/2021Vontobel Holding Ltd.10,000$0.25M0.0%N/A0.030%
2/12/2021Virtus ETF Advisers LLC18,849$0.47M0.2%+142.5%0.057%
2/12/2021Credit Agricole S A1,650$41K0.0%+37.5%0.005%
2/11/2021Northern Trust Corp298,531$7.37M0.0%-2.9%0.905%
2/11/2021Barclays PLC93,137$2.30M0.0%-80.8%0.282%
2/10/2021Rhumbline Advisers32,109$0.79M0.0%+2.4%0.097%
2/10/2021Renaissance Technologies LLC437,000$10.79M0.0%+78.6%1.325%
2/9/2021Advisory Services Network LLC1,275$31K0.0%+537.5%0.004%
2/9/2021Duality Advisers LP129,385$3.20M0.2%+321.4%0.392%
2/9/2021Bank of New York Mellon Corp105,034$2.59M0.0%-0.6%0.318%
2/9/2021ProShare Advisors LLC10,834$0.27M0.0%+27.6%0.033%
2/8/2021State Board of Administration of Florida Retirement System13,178$0.33M0.0%-5.2%0.040%
2/8/2021New York State Common Retirement Fund23,700$0.59M0.0%-22.7%0.072%
2/8/2021Russell Investments Group Ltd.121,441$3M0.0%-94.5%0.368%
2/5/2021Aperio Group LLC12,575$0.31M0.0%+25.4%0.038%
2/5/2021SG Americas Securities LLC31,625$0.78M0.0%+30.9%0.096%
2/4/2021Los Angeles Capital Management LLC40,017$0.99M0.0%+154.4%0.121%
2/4/2021State of Wisconsin Investment Board37,000$0.91M0.0%-11.1%0.112%
2/2/2021First Trust Advisors LP1,956,302$48.32M0.1%+29.6%5.930%
2/1/2021AE Wealth Management LLC19,328$0.48M0.0%+32.1%0.059%
2/1/2021Assenagon Asset Management S.A.178,622$4.41M0.0%-65.0%0.541%
1/29/2021Fisher Asset Management LLC59,970$1.48M0.0%-4.6%0.182%
1/29/2021Formidable Asset Management LLC10,000$0.27M0.1%N/A0.030%
1/28/2021Dupont Capital Management Corp7,683$0.19M0.0%-7.0%0.023%
1/26/2021Pinnacle Associates Ltd.133,828$3.31M0.1%-6.2%0.406%
1/20/2021Pacer Advisors Inc.4,303$0.11M0.0%+208.0%0.013%
12/4/2020Sei Investments Co.67,609$2.77M0.0%-65.0%0.205%
11/19/2020Schonfeld Strategic Advisors LLC5,758$0.24M0.0%-65.5%0.017%
11/17/2020Paloma Partners Management Co46,055$1.91M0.0%N/A0.140%
11/17/2020Voloridge Investment Management LLC314,839$13.05M0.1%+815.2%0.954%
11/17/2020Schonfeld Strategic Advisors LLC5,758$0.24M0.0%-65.5%0.017%
11/17/2020Boxer Capital LLC1,176,000$48.76M1.7%+833.3%3.565%
11/16/2020Cubist Systematic Strategies LLC37,555$1.56M0.0%+203.3%0.114%
11/16/2020AQR Capital Management LLC13,633$0.57M0.0%-31.1%0.041%
11/16/2020Greenlight Capital Inc.100,000$4.15M0.3%N/A0.303%
11/16/2020Squarepoint Ops LLC18,300$0.76M0.0%+42.2%0.055%
11/16/2020Weld Capital Management LLC8,512$0.35M0.1%N/A0.026%
11/16/2020Engineers Gate Manager LP39,570$1.64M0.1%+28.6%0.120%
11/16/2020Advisors Asset Management Inc.3,848$0.16M0.0%-56.4%0.012%
11/13/2020ProShare Advisors LLC8,493$0.35M0.0%-7.7%0.026%
11/13/2020Charles Schwab Investment Management Inc.201,070$8.34M0.0%-1.4%0.609%
11/13/2020Guggenheim Capital LLC35,357$1.47M0.0%+4.1%0.107%
11/13/2020Virtus ETF Advisers LLC7,774$0.32M0.2%+9.2%0.024%
11/12/2020AlphaCrest Capital Management LLC8,191$0.34M0.0%+35.3%0.025%
11/10/2020Fisher Asset Management LLC62,843$2.61M0.0%-6.4%0.191%
11/10/2020Bank Julius Baer & Co. Ltd Zurich815$34K0.0%-39.4%0.002%
11/9/2020SG Americas Securities LLC24,156$1M0.0%-58.3%0.073%
11/9/2020Rothschild & Co. Asset Management US Inc.221,611$9.19M0.2%-15.0%0.672%
11/9/2020Swiss National Bank59,700$2.48M0.0%+1.7%0.181%
11/9/2020State Board of Administration of Florida Retirement System13,898$0.58M0.0%+5.3%0.042%
11/6/2020Sei Investments Co.67,609$2.77M0.0%-65.0%0.205%
11/6/2020Trexquant Investment LP17,387$0.72M0.0%N/A0.053%
11/6/2020Aperio Group LLC10,024$0.42M0.0%+85.9%0.030%
11/6/2020Principal Financial Group Inc.60,736$2.52M0.0%+51.8%0.184%
11/5/2020California Public Employees Retirement System59,093$2.45M0.0%+3.0%0.179%
11/5/2020First Trust Advisors LP1,509,008$62.56M0.1%+86.6%4.575%
11/5/2020Alps Advisors Inc.42,057$1.74M0.0%-6.4%0.128%
11/4/2020American International Group Inc.15,505$0.64M0.0%-2.2%0.047%
11/4/2020Prospera Financial Services Inc683$28K0.0%N/A0.002%
11/4/2020Alps Advisors Inc.42,057$1.74M0.0%-6.4%0.128%
10/30/2020Sheaff Brock Investment Advisors LLC5,700$0.24M0.0%N/A0.017%
10/29/2020Dupont Capital Management Corp8,257$0.34M0.0%+45.7%0.025%
10/29/2020DekaBank Deutsche Girozentrale11,090$0.46M0.0%N/A0.034%
10/23/2020Pinnacle Associates Ltd.142,612$5.91M0.1%-3.5%0.432%
10/20/2020Nisa Investment Advisors LLC1,195$50K0.0%+512.8%0.004%
10/19/2020Pacer Advisors Inc.1,397$58K0.0%N/A0.004%
10/7/2020Assenagon Asset Management S.A.510,500$21.17M0.1%N/A1.548%
9/15/2020Two Sigma Advisers LP515,300$24.69M0.1%-4.5%1.562%
9/15/2020Schonfeld Strategic Advisors LLC16,695$0.80M0.0%N/A0.051%
9/4/2020Principal Financial Group Inc.40,000$1.92M0.0%+383.4%0.121%
8/26/2020Handelsbanken Fonder AB4,765$0.23M0.0%N/A0.014%
8/25/2020Nuveen Asset Management LLC104,045$4.99M0.0%-0.9%0.315%
8/24/2020Phocas Financial Corp.29,217$1.40M0.2%+67.9%0.089%
8/20/2020Charles Schwab Investment Management Inc.203,903$9.77M0.0%+21.5%0.618%
8/17/2020AQR Capital Management LLC19,784$0.95M0.0%+7.7%0.060%
8/17/2020Engineers Gate Manager LP30,775$1.47M0.1%+32.1%0.093%
8/17/2020California State Teachers Retirement System39,092$1.87M0.0%+2.2%0.119%
8/17/2020Jacobs Levy Equity Management Inc.49,457$2.37M0.0%+12.4%0.150%
8/17/2020Private Advisor Group LLC968$46K0.0%N/A0.003%
8/14/2020Canada Pension Plan Investment Board19,863$0.95M0.0%+101.8%0.060%
8/14/2020Pinnacle Associates Ltd.147,832$7.08M0.2%-1.7%0.448%
Data available starting January 2016

See Full Table
Intercept Pharmaceuticals logo
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. Its lead products candidate is the Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid in adults. The company is also developing Ocaliva for various indications, including nonalcoholic steatohepatitis (NASH); and other product candidates in various stages of clinical and preclinical development. It has a license agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. The company markets its products through an internal commercial organization, a contract sales organization, and third-party distributors. Intercept Pharmaceuticals, Inc. was incorporated in 2002 and is headquartered in New York, New York.
Read More

Today's Range

Now: $22.17
$22.16
$23.37

50 Day Range

MA: $23.47
$19.33
$31.19

52 Week Range

Now: $22.17
$18.15
$95.98

Volume

1,092,531 shs

Average Volume

1,109,445 shs

Market Capitalization

$731.96 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.85

Who are the company insiders with the largest holdings of Intercept Pharmaceuticals?

Intercept Pharmaceuticals' top insider shareholders include:
  1. SPA Genextra (Major Shareholder)
  2. Mark Pruzanski (CEO)
  3. David Shapiro (Insider)
  4. Ryan T Sullivan (General Counsel)
  5. Sandip Kapadia (CFO)
  6. Srinivas Akkaraju (Director)
  7. Paolo Fundaro (Director)
  8. Lisa Bright (Insider)
  9. Gail Cawkwell (SVP)
  10. Christian Weyer (EVP)
  11. David A Ford (Insider)
  12. Jason Campagna (Insider)
  13. Luca Benatti (Director)

Who are the major institutional investors of Intercept Pharmaceuticals?

Intercept Pharmaceuticals' top institutional shareholders include:
  1. Pacer Advisors Inc. — 0.01%

Which major investors are selling Intercept Pharmaceuticals stock?

Within the last quarter, ICPT stock was sold by these institutional investors:
  1. Pacer Advisors Inc.
Within the last year, company insiders that have sold Intercept Pharmaceuticals company stock include:
  1. SPA Genextra (Major Shareholder)
  2. Mark Pruzanski (CEO)
  3. David Shapiro (Insider)
  4. Ryan T Sullivan (General Counsel)
  5. Sandip Kapadia (CFO)
Millennial Uses Obscure 18-Digit Code to Beat Wall Street
Andrew Keene was "down and out"... until he found an obscure 18-digit "code" that let him see when hedge funds were making incredibly lucrative trades. He realized he could follow along - and take a slice of the profit. He's now a multi-millionaire.
And you can see how his strategy works here.
pixel